Calidi Biotherapeutics (NYSE American: CLDI) has announced plans to sell shares of its common stock and/or pre-funded warrants in a <a target ...

Is a cure on the way? Quinn Peterson remains cautious—again, those living with diabetes have been promised a cure for decades ...

In a report released today, Julian Harrison from BTIG maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report), with a ...

Oppenheimer analyst Leland Gershell maintained a Buy rating on SAB Biotherapeutics (SABS – Research Report) today and set a price target ...

Arcutis Biotherapeutics, Inc. (NASDAQ ... we are building a broad portfolio of ZORYVE solutions for clinicians in a multitude ...

FORE Biotherapeutics today announced that the Company will participate at the following investor conferences: Stifel 2024 Healthcare Conference. The Company will attend on Monday, November 18, and ...

As we work to have a remarkable impact on people’s lives, we are committed to exploring solutions to help patients ... multifunctional biotherapeutics designed to overcome cancer-driven ...

Oct. 31, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) and EvolveImmune Therapeutics, an immuno-oncology company developing next-generation biotherapeutics to overcome ... we are committed to exploring ...

As we work to have a remarkable impact on people's lives, we are committed to exploring solutions to help patients obtain access to our cancer medicines. For more information, please visit http ...

NEW YORK - Intelligent Bio Solutions Inc. (NASDAQ: INBS), a medical technology company known for its non-invasive drug testing technology, has reported preliminary unaudited revenue results for ...